Continental Advisors’s LeMaitre Vascular LMAT Stock Holding History

Continental Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-19,900	Closed	-$621K	–	121
2017 Q2	$621K	Sell	19,900 -15,000	-43%	-$433K	0.14%	112
2017 Q1	$860K	Sell	34,900 -50,000	-59%	-$1.17M	0.19%	102
2016 Q4	$2.15M	Hold	84,900	–	–	0.58%	60
2016 Q3	$1.68M	Hold	84,900	–	–	0.47%	66
2016 Q2	$1.21M	Hold	84,900	–	–	0.37%	82
2016 Q1	$1.32M	Hold	84,900	–	–	0.37%	78
2015 Q4	$1.47M	Hold	84,900	–	–	0.37%	82
2015 Q3	$1.03M	Hold	84,900	–	–	0.28%	105
2015 Q2	$1.02M	Hold	84,900	–	–	0.27%	98
2015 Q1	$711K	Hold	84,900	–	–	0.16%	118
2014 Q4	$649K	Hold	84,900	–	–	0.13%	125
2014 Q3	$584K	Hold	84,900	–	–	0.13%	122
2014 Q2	$702K	Hold	84,900	–	–	0.16%	104
2014 Q1	$685K	Hold	84,900	–	–	0.18%	95
2013 Q4	$680K	Hold	84,900	–	–	0.15%	122
2013 Q3	$569K	Hold	84,900	–	–	0.14%	116
2013 Q2	$555K	Buy	+84,900	New	+$535K	0.16%	103

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Continental Advisors's LMAT Position: Q3 2017 in Review

Continental Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2017, closing a stake of 19,900 shares — an estimated $621K sold.

Continental Advisors first reported a position in LMAT in Q2 2013 and held it in 17 quarters. The position peaked at $2.15M in Q4 2016. 148 funds tracked by Wall St. Rank hold LMAT as of Q3 2017.

Continental Advisors reported no remaining LeMaitre Vascular position as of Q3 2017 after selling out during the quarter.
Continental Advisors sold 19,900 LeMaitre Vascular shares in Q3 2017, an estimated $621K.
Continental Advisors first reported a position in LeMaitre Vascular in Q2 2013 and held it in 17 quarters.
Continental Advisors's LeMaitre Vascular position peaked at $2.15M in Q4 2016.
148 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2017.

Based on Continental Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.